3 results match your criteria: "Allegheny General Hospital and MCP Hahnemann University[Affiliation]"
Arch Pathol Lab Med
January 2002
Department of Pathology and Laboratory Medicine, Allegheny General Hospital and MCP Hahnemann University, Pittsburgh, PA 15212, USA.
Context: Measuring variation in clinician test ordering behavior for patients with similar indications is an important focus for quality management and cost containment.
Objective: To obtain information from physicians and nonphysicians regarding their test-ordering behavior and their knowledge of test performance characteristics for diagnostic tests used to work up patients with lung lesions suspicious for cancer.
Design: A self-administered, voluntary, anonymous questionnaire was distributed to 452 multiple-specialty physicians and 500 nonphysicians in academic and private practice in Pennsylvania, Iowa, and North Carolina.
Cancer
November 2001
Department of Pathology and Laboratory Medicine, Allegheny General Hospital and MCP Hahnemann University, Pittsburgh, Pennsylvania 15212, USA.
Background: The use of the MIB-1 labeling index (LI) as a potential prognostic marker for patients with primary brain tumors is controversial. Many studies advocating its prognostic usefulness have suggested discrete MIB-1 LI cut-off values, above which patients have significantly worse outcomes. However, interobserver variability associated previously with MIB-1 LI calculation has not been reported despite the fact that the degree of interobserver variability impacts the clinical usefulness of such cut-off values.
View Article and Find Full Text PDFJAMA
December 2000
Center for Genomic Sciences and Department of Human Genetics, Allegheny General Hospital and MCP Hahnemann University, Pittsburgh, Pa.